Top

Published in:

01-12-2017 | News item

Warnings of histamine-related ADRs with gentamicin

Published in: Reactions Weekly | Issue 1/2017

Excerpt

Selected batches of the gentamicin sulphate active pharmaceutical ingredient (API) may contain excessive levels of histamine as a residual of the manufacturing process, says the UK's MHRA. …

Medicines and Healthcare products Regulatory Agency (UK). Gentamicin: potential for histamine-related adverse drug reactions with some batches. Drug Safety Update 11: 2, No. 4, Nov 2017. Available from: URL: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/662330/DSU-Nov-pdf.pdf

Title: Warnings of histamine-related ADRs with gentamicin
Publication date: 01-12-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-39281-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Warnings of histamine-related ADRs with gentamicin

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Methotrexate

Norepinephrine

Ropinirole/rotigotine

Dexamethasone

Rociletinib

Bupivacaine/clonidine/hydromorphone